Daron Street

470 total citations
11 papers, 271 citations indexed

About

Daron Street is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Daron Street has authored 11 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Reproductive Medicine, 4 papers in Obstetrics and Gynecology and 3 papers in Oncology. Recurrent topics in Daron Street's work include Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Immunotherapy and Immune Responses (2 papers). Daron Street is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Immunotherapy and Immune Responses (2 papers). Daron Street collaborates with scholars based in United States, United Kingdom and France. Daron Street's co-authors include Martee L. Hensley, John A. Blessing, James J. Burke, Carolyn Y. Muller, Andreas M. Kaufmann, Bradley J. Monk, Lutz Gissmann, Susan G. Fisher, William P. McGuire and Robert L. Coleman and has published in prestigious journals such as Journal of Clinical Oncology, Gynecologic Oncology and Cellular Immunology.

In The Last Decade

Daron Street

11 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daron Street United States 8 88 88 71 68 64 11 271
Shujie Pang China 8 52 0.6× 64 0.7× 114 1.6× 89 1.3× 61 1.0× 22 282
Koji Nishino Japan 10 89 1.0× 49 0.6× 91 1.3× 113 1.7× 36 0.6× 20 259
Gonghua Qi China 10 102 1.2× 105 1.2× 91 1.3× 157 2.3× 58 0.9× 16 365
Boer Shan China 12 105 1.2× 145 1.6× 149 2.1× 81 1.2× 48 0.8× 36 358
JH Kim South Korea 7 95 1.1× 71 0.8× 65 0.9× 63 0.9× 24 0.4× 18 311
Elena Giudice Italy 8 134 1.5× 50 0.6× 74 1.0× 93 1.4× 27 0.4× 33 240
ME Sherman United States 5 81 0.9× 50 0.6× 145 2.0× 116 1.7× 19 0.3× 6 348
Beata Maćkowiak-Matejczyk Poland 8 96 1.1× 66 0.8× 125 1.8× 57 0.8× 16 0.3× 14 243
Sima Kadkhodayan Iran 8 30 0.3× 163 1.9× 123 1.7× 71 1.0× 39 0.6× 19 314
Miłosz Wilczyński Poland 10 63 0.7× 71 0.8× 72 1.0× 140 2.1× 22 0.3× 32 290

Countries citing papers authored by Daron Street

Since Specialization
Citations

This map shows the geographic impact of Daron Street's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daron Street with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daron Street more than expected).

Fields of papers citing papers by Daron Street

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daron Street. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daron Street. The network helps show where Daron Street may publish in the future.

Co-authorship network of co-authors of Daron Street

This figure shows the co-authorship network connecting the top 25 collaborators of Daron Street. A scholar is included among the top collaborators of Daron Street based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daron Street. Daron Street is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Street, Daron, David Starks, Haider Mahdi, et al.. (2024). A phase I/II study of maplirpacept in combination with pegylated liposomal doxorubicin (PLD) in patients with platinum-resistant ovarian cancer (OC): Phase 1 results.. Journal of Clinical Oncology. 42(16_suppl). e17546–e17546. 2 indexed citations
2.
3.
Coleman, Robert L., Michael W. Sill, Premal H. Thaker, et al.. (2013). A phase II evaluation of AZD6244, a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study. Gynecologic Oncology. 130(1). e12–e13. 4 indexed citations
4.
Carmen, Marcela G. del, John P. Micha, Laurie Small, et al.. (2012). A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer. Gynecologic Oncology. 126(3). 369–374. 29 indexed citations
5.
Monk, Bradley J., John A. Blessing, Daron Street, et al.. (2011). A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study. Gynecologic Oncology. 124(1). 48–52. 67 indexed citations
6.
7.
Street, Daron, et al.. (2010). Breast and cervical cancer. 15 indexed citations
8.
Gordon, Alan N., Lina Asmar, Mark Messing, et al.. (2004). Phase II study of sequential doublets: topotecan and carboplatin, followed by paclitaxel and carboplatin, in patients with newly diagnosed advanced ovarian cancer. Gynecologic Oncology. 94(2). 533–539. 7 indexed citations
9.
Gissmann, Lutz, et al.. (1997). Regulation of Human Papillomavirus Type 18in Vivo:Effects of Estrogen and Progesterone in Transgenic Mice. Gynecologic Oncology. 66(2). 202–208. 33 indexed citations
10.
Street, Daron, Andreas M. Kaufmann, Andrew Vaughan, et al.. (1997). Interferon-γ Enhances Susceptibility of Cervical Cancer Cells to Lysis by Tumor-Specific Cytotoxic T Cells. Gynecologic Oncology. 65(2). 265–272. 36 indexed citations
11.
Kaufmann, Andreas M., et al.. (1996). Expression of CD80 Enhances Immunogenicity of Cervical Carcinoma Cellsin Vitro. Cellular Immunology. 169(2). 246–251. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shujie Pang Breakdown of academic impact, for papers by Koji Nishino Breakdown of academic impact, for papers by Gonghua Qi Breakdown of academic impact, for papers by Boer Shan Breakdown of academic impact, for papers by JH Kim Breakdown of academic impact, for papers by Elena Giudice Breakdown of academic impact, for papers by ME Sherman Breakdown of academic impact, for papers by Beata Maćkowiak-Matejczyk Breakdown of academic impact, for papers by Sima Kadkhodayan Breakdown of academic impact, for papers by Miłosz Wilczyński
Rankless by CCL
2026